How should adrenaline (epinephrine) be administered to an adult for anaphylaxis and for cardiac arrest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Administer Adrenaline to an Adult

For anaphylaxis, administer epinephrine 0.3-0.5 mg (1:1000 concentration) intramuscularly into the anterolateral thigh immediately, repeating every 5-15 minutes as needed; for cardiac arrest, give 1 mg IV/IO every 3-5 minutes during resuscitation. 1, 2

Anaphylaxis Administration

First-Line Treatment: Intramuscular Route

Intramuscular injection into the lateral thigh is the preferred initial route because it produces rapid peak plasma concentrations, is safe, and is easy to administer 1. The 2020 AHA Guidelines give this a Class I recommendation.

Dosing specifics:

  • Adults ≥30 kg (66 lbs): 0.3-0.5 mg of 1:1000 (1 mg/mL) solution IM
  • Inject into the anterolateral aspect of the thigh (through clothing if necessary)
  • Use a needle at least 1/2 to 5/8 inch long to ensure intramuscular delivery
  • Repeat every 5-15 minutes as needed based on clinical response 1, 2

Critical pitfall: Do NOT inject into buttocks, digits, hands, or feet due to risk of tissue necrosis from vasoconstriction 2. Avoid repeated injections at the same site.

Alternative Routes for Anaphylaxis

Intravenous route (when IV access already established):

  • Dose: 0.05-0.1 mg of 1:10,000 concentration (0.1 mg/mL)
  • This is 5-10% of the cardiac arrest dose
  • Class IIa recommendation for anaphylactic shock 1
  • Warning: Confusion between concentrations has caused fatal overdoses 3. The cardiac arrest dose (1 mg IV push) given to anaphylaxis patients has caused severe systolic dysfunction and potentially lethal cardiac complications.

Continuous IV infusion:

  • Start at 5-15 μg/min for refractory anaphylactic shock
  • Allows careful titration and avoids overdosing
  • Class IIa recommendation for patients not in cardiac arrest 1
  • May be considered for post-arrest shock (Class IIb) 1

Monitoring and Adjunctive Care

  • Close hemodynamic monitoring is mandatory (Class I) 1
  • Position patient supine with legs elevated to improve cerebral/cardiac circulation
  • Prepare for potential airway management—laryngeal edema can develop rapidly, potentially requiring cricothyroidotomy 1
  • No absolute contraindications to epinephrine in anaphylaxis, even in elderly or cardiac patients 4

Important: Antihistamines, beta-agonists, and corticosteroids are second-line only and have no proven benefit during anaphylaxis-induced cardiac arrest 1.

Cardiac Arrest Administration

Standard Protocol

For cardiac arrest from any cause, including anaphylaxis:

  • 1 mg IV/IO every 3-5 minutes during resuscitation
  • Use 1:10,000 concentration (0.1 mg/mL) = 10 mL per dose
  • Operationally: give after initial dose, then every second CPR cycle 5

Timing considerations:

  • In shockable rhythms (VF/pVT): Prioritize rapid defibrillation first; give epinephrine after initial defibrillation attempts fail 5
  • In non-shockable rhythms (asystole/PEA): Give epinephrine as soon as IV/IO access obtained
  • One observational study showed 10% lower survival in hospitals giving epinephrine before initial defibrillation in shockable rhythms 5

Evidence Limitations

The 2025 AHA Guidelines acknowledge that while epinephrine consistently improves return of spontaneous circulation (ROSC) and survival to hospital admission, evidence for improved neurologic outcomes remains limited 5. The PARAMEDIC2 trial showed 12-month survival favored epinephrine, but no difference in 6-month functional neurologic outcome 5.

No benefit from:

  • High-dose epinephrine (>1 mg per dose)
  • Vasopressin alone or combined with epinephrine
  • More frequent dosing intervals 5

Route of Administration

  • IV or intraosseous (IO) are equivalent routes
  • Central venous access offers no advantage over peripheral IV and risks delays in compressions 5
  • IO epinephrine likely effective at comparable doses for anaphylaxis, though not specifically studied 1

Key Safety Considerations

Concentration confusion is the most dangerous error:

  • Anaphylaxis = 1:1000 (1 mg/mL) IM
  • Cardiac arrest = 1:10,000 (0.1 mg/mL) IV
  • Anaphylactic shock IV = 1:10,000 (0.1 mg/mL) at much lower doses (0.05-0.1 mg)

Six of seven surveyed hospitals did not stock appropriately labeled prefilled IM syringes, contributing to dosing errors 3. Ensure clear labeling and separate storage of different concentrations.

Inspect solution before use: Do not administer if colored, cloudy, or contains particulate matter 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.